Skip to content
Review Open access

Pretreatment Health-Related Quality of Life and Survival in Head and Neck Cancer: A Meta-Analysis.

Oct 2026 · The Laryngoscope · 0 citations · 34 references
Medicine

TL;DR

Pretreatment HRQoL provides multidimensional prognostic information, with Global QoL and physical, role, emotional, and social functioning showing the most consistent evidence, and these domains may help prioritize pretreatment supportive-care assessment.

Abstract

Objective

To quantify associations between pretreatment patient-reported health-related quality of life (HRQoL) domains and overall survival in head and neck cancer. DATA SOURCES PubMed, Embase, and Web of Science were searched from inception through July 27, 2026. REVIEW

Methods

Longitudinal studies evaluating validated patient-reported HRQoL as a prognostic exposure were included. Adjusted hazard ratios (HRs) for overall survival were harmonized to a 10-point worsening and pooled by domain using restricted maximum-likelihood random-effects models. Risk of bias, multiplicity, leave-one-out stability, cohort overlap, residual-confounding sensitivity, and reporting completeness were evaluated.

Results

Thirty-two independent studies in 40 publications were included; 43 estimates contributed to meta-analyses of 10 domains. Worse Global QoL (HR, 1.11; 95% CI, 1.08-1.14), physical functioning (1.16; 1.13-1.20), role functioning (1.09; 1.07-1.11), and social functioning (1.09; 1.06-1.12) were consistently associated with higher mortality and remained leave-one-out stable. Swallowing was associated with mortality (1.15; 1.02-1.29) but was sensitive to one study. Dyspnea was associated with higher mortality in the primary analysis (4 studies; HR, 1.16; 95% CI, 1.01-1.33), but the estimate was heterogeneous and unstable.

Conclusion

Pretreatment HRQoL provides multidimensional prognostic information, with Global QoL and physical, role, emotional, and social functioning showing the most consistent evidence. These domains may help prioritize pretreatment supportive-care assessment, whereas sensitivity-limited or very-low-certainty findings require further confirmation and should not be interpreted as actionable treatment targets. LEVEL OF EVIDENCE N/A. TRIAL REGISTRATION PROSPERO number: CRD420261461389.

Read PDF

Similar papers

Open access Oct 2026

Health-Related Quality of Life in Glioma Subtypes: A Pooled Analysis of 16 Randomized Trials from the CODAGLIO 2.0 project.

BACKGROUND It is unclear whether glioma subtypes differ in health-related quality of life (HRQoL) over time. METHODS We analyzed data from the CODAGLIO 2.0 database, comprising 16 randomized controlled trials with HRQoL assessed using the EORTC QLQ-C30 and QLQ-BN20 questionnaires. Differences in mean HRQoL at baselin...

O. A. Asogwa, L. Dirven, M. J. van den Bent et al. · 0 citations
Review Open access Oct 2026

The prognostic value of physical functioning on survival in patients with nonsmall cell lung cancer: a systematic review and meta-analysis

Background Physical functioning has emerged as a potentially valuable prognostic indicator in patients with nonsmall cell lung cancer (NSCLC). This systematic review and meta-analysis aimed to evaluate the prognostic value of objectively measured components of physical functioning on survival outcomes across treatment...

E. Arents, S. Haesevoets, Marthe Van Overbeke et al. · 0 citations
Oct 2026

Symptom Burden and Quality of Life in Multiple Myeloma: A Multicenter Study.

Higher symptom burden was consistently associated with poorer quality of life, especially in physical functioning, pain, and disease-specific concerns, in this multicenter cohort of patients with multiple myeloma.

J. Alkrinawi, Nizar Abu Hamdeh, M. Alnees et al. · 0 citations
Review Oct 2026

Abstract C028: Health related quality of life status among Black prostate cancer survivors

Globally, Black men suffer the greatest prostate cancer (CaP) burden. This study evaluated health-related quality of life (HRQOL) among Black prostate cancer survivors (CaPS) and compared their HRQOL by stage. We used a validation study to compare the HRQOL outcomes between the validation study and our sample....

K. Ashing, Floyd Willis, Christopher Williams et al. · 0 citations
Open access Sep 2026

Association between preoperative EQ-5D visual analogue scale score and recurrence-free survival after lung cancer resection.

OBJECTIVE To investigate the prognostic impact of preoperative self-reported global health status, assessed with the EQ-5D visual analogue scale (VAS), on recurrence-free survival (RFS) in patients undergoing resection for clinical stage I non-small cell lung cancer (NSCLC). METHODS This retrospective study included...

H. Ichimura, Keisuke Kobayashi, Masahiko Gosho et al. · 0 citations
Review Open access Nov 2026

Factors associated with cancer-related fatigue in breast cancer patients: a systematic review and meta-analysis

Cancer-related fatigue (CRF) remains one of the most common and persistent complications among breast cancer survivors, profoundly impairing their psychosocial well-being. Although various predictors have been proposed, existing evidence yields inconsistent findings. This study aimed to systematically synthesize mu...

Bai-Ru Ba, Xiao-Feng Wang, Hong Ye et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.